Drug
Trifluridine Tipiracil Bevacizumab
Trifluridine Tipiracil Bevacizumab: highest development phase Phase 2, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| Trifluridine/tipiracil + bevacizumab NCT02743221 | Phase 2 | Metastatic Colorectal Cancer |
Latest
No recent events.
Follow Trifluridine Tipiracil Bevacizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.